HCV co-infection does not affect the TREC/IL-7 pathway in HIV disease

Eur Rev Med Pharmacol Sci. 2008 Jan-Feb;12(1):67-9.

Abstract

About thymic output, little is known in HIV-HCV co-infected patients. Thymic output can be measured by T-cell receptor excision circles (TREC) present in the so called "recent thymic emigrants" (RTEs). We have analyzed, by Real time PCR, sj-TREC+ cells in 11 patients with HIV-HCV co-infection; all patients were treated with highly active antiretroviral therapy (HAART), but were naive for interferon anti-HCV treatment. The results were compared with those of 21 age-matched normal donors. These data show no reduction of sj-TREC+ cells in co-infection. In 5 co-infected patients, IL-7 plasmatic levels were also evaluated by ELISA and no difference between co-infected patients and normal controls was found. Taken together, our data, although limited by the numerosity of the sample, may suggest that HCV co-infection does not affect the TREC/IL-7 pathway in HIV disease.

Publication types

  • Letter

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • Enzyme-Linked Immunosorbent Assay
  • HIV Infections / complications
  • HIV Infections / immunology
  • HIV Infections / physiopathology*
  • Hepatitis C / complications*
  • Humans
  • Interleukin-7 / metabolism*
  • Polymerase Chain Reaction
  • Receptors, Antigen, T-Cell / metabolism*
  • Thymus Gland / immunology

Substances

  • Interleukin-7
  • Receptors, Antigen, T-Cell